Vantage logo

Ash 2022 roundup

Evaluate Vantage's coverage of the Ash 2022 congress.

Vantage logo

Biotech catalysts on the horizon

The second quarter should bring pivotal data for Karuna and key cardiomyopathy results for Alnylam, while Ionis's eplontersen lags in amyloidosis.